Asymmetric Synthesis of Sulindac by Iron-Catalyzed Sulfoxidation

An iron-catalyzed asymmetric sulfide oxidation is the key step in the synthesis of the non-steroidal anti-inflammatory drug Sulindac. Both enantiomers of the chiral product can be prepared with 92% ee in good yield.